Not exact matches
While more
research is needed, Professor Qiao and his team believe that their
discovery is the beginning of unlocking a new treatment for antibiotic - resistant
pathogens.
The
discovery, made in
research laboratories at the University of Michigan Medical School and the U.S. Food and Drug Administration, is published in the online journal PLoS
Pathogens.
«Liverworts are showing great promise as a model plant system and this
discovery that they can be colonised by
pathogens of flowering plants makes them a valuable model plant to continue
research into plant - microbe interactions.»
Nanotheraputics for Antibiotic Resistent Emerging Bacterial
pathogens (NAREB) European
Research Infrastructures for Poverty Related Diseases (EURIPED) Biomarkers for enhanced vaccines immunosafety (BioVacSafe) European network of vaccine research and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TB
Research Infrastructures for Poverty Related Diseases (EURIPED) Biomarkers for enhanced vaccines immunosafety (BioVacSafe) European network of vaccine
research and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TB
research and development TRANSVAC Advancing novel and promising TB vaccine candidates from
discovery to preclinical and early clinical development (TBVAC2020)
Objective: To provide data - driven and computational infrastructures and data - sharing platforms to support large - scale, system - level data integration and modeling, and enable predictive biology for
pathogens and host -
pathogen interactions for
discovery research, clinical investigation, and therapeutic development for infectious diseases.
The CPM
research and
discovery programs bring together a dynamic and interactive team of faculty in the Schools of Medicine, Public Health, and Arts & Sciences, who enjoy cross-translational approaches to address critical
research questions to better understand rare, neglected and / or emerging
pathogens.